Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast … Continue reading Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation